LATEST ALERTS
This report provides an estimate of the market size of delta-8 THC in the US for 2023, and breakdowns by form factor and geographical regions, as well as scenarios for possible future growth
Kombinat Konopny CEO and founder Maciej Kowalski talks to podcast host Oliver Prescott about the company’s win in Poland’s high court, subsequent changes in the industry and current cannabis food policy in Europe
Twitter has claimed to have made another “major” step forward in cannabis advertising. But again the devil is in the details, which remain vague and contradictory
Mexican president Andrés Manuel López Obrador alleged that cannabis permits awarded to companies linked to former president Vicente Fox in 2018 involved influence peddling and corruption
Avicanna in Toronto reported total fiscal 2022 revenue up 24% from fiscal 2021, while in Pennsylvania, Zynerba Pharmaceuticals reduced its net loss last year by over $2m
This report highlights key findings from a consumer survey conducted by CannIntelligence on the usage and perception of delta-8 THC in the US
This report provides a detailed overview of Latvia’s regulatory framework for CBD and cannabis, as well as other minor cannabinoids, covering all policy areas
The Ministry of Health in the Czech Republic has unveiled plans to ban the sale of hexahydrocannabinol (HHC) this July, triggering criticism from local industry insiders
The sale of cannabinoid pouches in Belgium has been banned along with nicotine pouches on the grounds the latter pose a danger to public health, particularly due to their potential for addiction
This report provides a detailed overview of the regulatory framework in place for CBD, hemp and cannabis, covering everything from processing and cultivation to finished products, import/export and the country’s cannabis regime
US cannabis company Columbia Care recorded a positive performance in 2022, despite macroeconomic headwinds that impacted consumers as well as wholesale market pricing
Biotechnology company 22nd Century Group has announced a new three-year exclusive licence and distribution agreement with the US cannabis company Cookies
This snapshot of Japan’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
This snapshot of Switzerland’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Altria is considering including cannabis as well as caffeine pouches in its offering of non-nicotine products as part of its growth strategy
While disposable e-cigs are the fastest growing category in the industry, they are also the fastest growing source of concern for policymakers. This report discusses how and why these products could eventually be banned in the EU
This report provides a summary of the current regulatory framework in place for CBD, hemp and cannabis in Andorra
A hemp industry under threat, a recreational cannabis market in limbo, and an uncertain political climate have left the future of cannabis in Virginia unclear and many grappling with the fallout of recent legal activity
CannIntelligence’s online retailer database provides information on the CBD and intoxicating hemp-derived cannabinoid (IHDC) industries.
Key cannabis industry players in the US have scaled back their businesses this year, citing the “challenges of the current market”
HHC is the most popular intoxicating hemp-derived cannabinoid (IHDC) in Europe, while delta-8 THC remains top in the US, according to CannIntelligence analysts
This report offers a comprehensive overview of the current regulatory framework in place in Peru for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
US-based 22nd Century’s cannabinoid division saw 19% quarterly revenue growth in the fourth quarter of 2022 despite a November fire disrupting operations at a California facility
Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
